Hypertension, Thrombosis, Kidney Failure, and Diabetes: Is COVID-19 an Endothelial Disease? A Comprehensive Evaluation of Clinical and Basic Evidence
subject: Blood Pressure, Acute kidney injury, coronavirus, ACE2, Cytokine storm, COVID, catepsin
description: The symptoms most commonly reported by patients affected by coronavirus disease (COVID-19) include cough, fever, and shortness of breath. However, other major events usually observed in COVID-19 patients (e.g., high blood pressure, arterial and venous thromboembolism, kidney disease, neurologic disorders, and diabetes mellitus) indicate that the virus is targeting the endothelium, one of the largest organs in the human body. Herein, we report a systematic and comprehensive evaluation of both clinical and preclinical evidence supporting the hypothesis that the endothelium is a key target organ in COVID-19, providing a mechanistic rationale behind its systemic manifestations.
creator: Celestino Sardu, Raffaele Marfella, Marco Bruno Morelli, Xujun Wang, Jessica Gambardella, Gaetano Santulli
source: Journal of Clinical Medicine
publisher: MDPI AG
date: 2020
identifier: DOI: 10.3390/jcm9051417
coverage: Medicine